Vitalhub Corp. (TSE:VHI - Get Free Report) shares hit a new 52-week low during trading on Tuesday after Royal Bank Of Canada downgraded the stock from a moderate buy rating to a hold rating. The company traded as low as C$6.46 and last traded at C$6.69, with a volume of 133,484 shares trading hands. The stock had previously closed at C$6.62.
Other analysts also recently issued research reports about the company. Stifel Nicolaus reduced their price objective on Vitalhub from C$11.00 to C$10.00 and set a "buy" rating for the company in a research report on Monday. Raymond James Financial decreased their price target on shares of Vitalhub from C$11.00 to C$10.50 and set an "outperform" rating on the stock in a research note on Monday. ATB Cormark Capital Markets lowered their price target on shares of Vitalhub from C$12.00 to C$10.25 and set an "outperform" rating on the stock in a report on Monday. TD lowered their target price on shares of Vitalhub from C$13.00 to C$9.50 and set a "buy" rating on the stock in a research note on Monday. Finally, Canaccord Genuity Group dropped their price target on shares of Vitalhub from C$15.00 to C$14.50 and set a "buy" rating for the company in a research report on Monday. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Vitalhub currently has an average rating of "Moderate Buy" and an average target price of C$10.86.
Get Our Latest Stock Report on VHI
Key Vitalhub News
These are some of the VHI news items that stood out recently:
- Positive Sentiment: Despite reducing their targets, Scotia, Stifel, TD, National Bank Financial, Raymond James, Canaccord Genuity and ATB Cormark maintained Buy, Outperform or Sector Outperform ratings. Their revised targets remain above the roughly C$6.62 reference price, suggesting analysts still see potential upside. Analyst rating updates
- Neutral Sentiment: An article frames Vitalhub as integrating past acquisitions while preparing for further deals, a strategy that could support growth but also requires successful execution. Vitalhub: Digesting Acquisitions While Preparing For More
- Negative Sentiment: Royal Bank of Canada downgraded Vitalhub from Moderate Buy to Hold (also reported as Sector Perform). In addition, seven firms cut their price targets—including Scotia to C$9.00, TD to C$9.50 and National Bank Financial to C$10.00—indicating a more cautious reassessment that may weigh on sentiment. Vitalhub Downgraded to Sector Perform at RBC
Vitalhub Trading Up 0.6%
The stock has a fifty day moving average of C$7.53 and a two-hundred day moving average of C$7.57. The stock has a market capitalization of C$421.84 million, a price-to-earnings ratio of 55.50, a PEG ratio of 1.18 and a beta of 1.37.
Vitalhub (TSE:VHI - Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported C$0.04 EPS for the quarter. The company had revenue of C$31.91 million for the quarter. Vitalhub had a return on equity of 4.03% and a net margin of 8.63%. Equities analysts expect that Vitalhub Corp. will post 0.23 earnings per share for the current year.
About Vitalhub
(
Get Free Report)
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.